887 related articles for article (PubMed ID: 27533032)
1. Structure-based discovery of opioid analgesics with reduced side effects.
Manglik A; Lin H; Aryal DK; McCorvy JD; Dengler D; Corder G; Levit A; Kling RC; Bernat V; Hübner H; Huang XP; Sassano MF; Giguère PM; Löber S; Da Duan ; Scherrer G; Kobilka BK; Gmeiner P; Roth BL; Shoichet BK
Nature; 2016 Sep; 537(7619):185-190. PubMed ID: 27533032
[TBL] [Abstract][Full Text] [Related]
2. The G-protein-biased agents PZM21 and TRV130 are partial agonists of μ-opioid receptor-mediated signalling to ion channels.
Yudin Y; Rohacs T
Br J Pharmacol; 2019 Sep; 176(17):3110-3125. PubMed ID: 31074038
[TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.
Zhao Z; Huang T; Li J
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190
[TBL] [Abstract][Full Text] [Related]
4. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
[TBL] [Abstract][Full Text] [Related]
6. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
[TBL] [Abstract][Full Text] [Related]
7. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.
Gillis A; Gondin AB; Kliewer A; Sanchez J; Lim HD; Alamein C; Manandhar P; Santiago M; Fritzwanker S; Schmiedel F; Katte TA; Reekie T; Grimsey NL; Kassiou M; Kellam B; Krasel C; Halls ML; Connor M; Lane JR; Schulz S; Christie MJ; Canals M
Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234959
[TBL] [Abstract][Full Text] [Related]
8. The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.
Hill R; Disney A; Conibear A; Sutcliffe K; Dewey W; Husbands S; Bailey C; Kelly E; Henderson G
Br J Pharmacol; 2018 Jul; 175(13):2653-2661. PubMed ID: 29582414
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation.
Jiang X; Li S; Zhang H; Wang LL
Comput Biol Chem; 2021 Feb; 90():107405. PubMed ID: 33184004
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
Ding H; Kiguchi N; Perrey DA; Nguyen T; Czoty PW; Hsu FC; Zhang Y; Ko MC
Br J Anaesth; 2020 Oct; 125(4):596-604. PubMed ID: 32819621
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain.
Chen XT; Pitis P; Liu G; Yuan C; Gotchev D; Cowan CL; Rominger DH; Koblish M; Dewire SM; Crombie AL; Violin JD; Yamashita DS
J Med Chem; 2013 Oct; 56(20):8019-31. PubMed ID: 24063433
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.
Kudla L; Bugno R; Skupio U; Wiktorowska L; Solecki W; Wojtas A; Golembiowska K; Zádor F; Benyhe S; Buda S; Makuch W; Przewlocka B; Bojarski AJ; Przewlocki R
Br J Pharmacol; 2019 Dec; 176(23):4434-4445. PubMed ID: 31347704
[TBL] [Abstract][Full Text] [Related]
15. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
[TBL] [Abstract][Full Text] [Related]
17. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
[TBL] [Abstract][Full Text] [Related]
18. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
19. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
[TBL] [Abstract][Full Text] [Related]
20. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]